Original Articles
Vol. 10 (2018): Review Articles, Original Articles, Scientific Letters, Case Reports

CUTANEOUS MANIFESTATIONS OF PRIMARY IMMUNODEFICIENCY DISEASES IN TUNISIAN CHILDREN

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: August 27, 2018
Accepted: October 15, 2018
Published: October 30, 2018
2114
Views
1106
Downloads
335
HTML

Authors

Abstract. Skin manifestations are frequent among patients with primary immunodeficiency diseases (PIDs). Their prevalence varies according to the type of immunodeficiency. This review provides the reader with an up-to-date summary of the common dermatologic manifestations of PIDs among Tunisian children. We conducted a prospective study on two hundred and ninety children with immune deficiency. Demographic details (including age, sex, and consanguinity) with personal and family history were recorded. Special attention was paid to cutaneous manifestations. Dermatological involvements were grouped according to the etiology of their most prominent sign. Cutaneous manifestations were found in 164 patients (56.5%). They revealed the diagnosis of PIDs in 71 patients (24.5 %). The mean age at presentation was 21 months. Overall the most prominent cutaneous alterations were infectious. They accounted for 106 cases (36.55%). The most prevalent causes of cutaneous infections were bacterial: 93 cases (32.06%). Immuno-allergic skin diseases were among the common findings in our study. These include eczematous dermatitis found in 62 cases (21.38%). Malignancy related PIDs was seen in a boy with Wiskott Aldrich syndrome. He developed Kaposi’s sarcoma at the age of 14 months. Cutaneous changes are common among children with PIDs. In pediatric patients with failure to thrive, chronic refractory systemic manifestations often present in other family members, recurrent cutaneous infections unresponsive to adequate therapy, atypical forms of eczematous dermatitis or unusual features should arouse the suspicion of PIDs and prompt specialized immunologic consultation should be made.

Downloads

Download data is not yet available.

Citations

Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, Etzioni A, Holland SM, Klein C, Nonoyama S, Ochs HD, Oksenhendler E, Puck JM, Sullivan KE, Tang ML, Franco JL, Gaspar HB. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015 Nov; 35(8):696-726. http://dx.doi.org/10.1007/s10875-015-0201-1. PMID:26482257
Lehman H. Skin manifestations of primary immune deficiency. Clin Rev Allergy Immunol2014;46:112 119.http://dx.doi.org/10.1007/s12016-013-8377-8. PMID:23760761
Smitt JHS, Wulffraat NM, Kuijpers TW . The skin in primary immunodeficiency disorders. Eur J Dermatol 2005 ;15: 425-432. PMID:16280293
Moin A , Farhoudi A, Moin M, Pourpak Z, Bazargan N . Cutaneous Manifestations of Primary Immunodeficiency Diseases in Children. Iran J Allergy Asthma Immunol 2006;5:121-126.http://dx.doi.org/ 05.03/ijaai.121126 PMID:17237563
Al Herz W, Nanda A. Skin manifestations in primary immunodeficient children. Pediatr Dermatol 2011; 28:494 501.http://dx.doi.org/ 10.1111/j.1525-1470.2011.01409.x.PMID: 21453308
Suleman Elfaituri S, Matoug I .Cutaneous Manifestations of Primary Immunodeficiency Diseases in Libyan Children. J Clin Dermatol Ther 2017;4: 025. http://dx.doi.org/10.24966/CDT-8771/100025
Yu JE , Azar AE , Chong HJ , Jongco AM 3rd , Prince BT . Considerations in the Diagnosis of Chronic Granulomatous Disease. J Pediatric Infect Dis Soc 2018; 7(suppl 1):S6-S11. http://dx.doi.org/10.1093/jpids/piy007. PMID: 29746674
Johnston S L. Clinical Immunology Review Series: An approach to the patient with recurrent superficial abscesses. Clin Exp Immunol 2008 ; 152(3): 397–405. http://dx.doi.org/10.1111/j.1365-2249.2008.03640.x . PMID: 18422735
Movahedi Z, Norouzi S, Mamishi S, Rezaei N. BCGiosis as a presenting feature of a child with chronic granulomatous disease. Braz J Infect Dis 2011;15: 83-86.PMID: 21412596
Galal N , Boutros J, Marsafy A, Kong XF, Feinberg J, Casanova JL, Boisson-Dupuis S, Bustamante J. Mendelian susceptibility to mycobacterial disease in egyptian children.Mediterr J Hematol Infect Dis 2012 . http://dx.doi.org/10.4084/MJHID.2012.033. PMID:22708048
Norouzi S, Aghamohammadi A, Mamishi S, et al. Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. J Infect 2012;64:543–54.http://dx.doi.org/ 10.1016/j.jinf.2012.03.012. PMID:22430715
De Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S ,et al. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 2010; 89: 381-402. http://dx.doi.org/ 10.1097/MD.0b013e3181fdd832. PMID:21057261
Guirat-Dhouib N , Baccar Y, Mustapha IB, Ouederni M, Chouaibi S, El Fekih N, Barbouche MR, Fezaa B, Kouki R, Hmida S, Mellouli F, Bejaoui M. Oral HPV infection and MHC class II deficiency (A study of two cases with atypical outcome). Clin Mol Allergy. 2012 Apr 23;10(1):6.http://dx.doi.org/10.1186/1476-7961-10-6. PMID: 22524894
Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD. Dermatological manifestations of autoimmune polyendocrinopathy candidiasis ectodermal dystrophy syndrome. Br J Dermatol 2006;154:1088 1093 .http://dx.doi.org /10.1111/j.1365-2133.2006.07166.x. PMID:16704638
Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood 2004;103:456-464.http://dx.doi.org/ 10.1182/blood-2003-05-1480. PMID:12969986
Catucci M, Castiello MC, Pala F, Bosticardo M, Villa A. Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol. 2012 ;3:209. http://dx.doi.org/10.3389/fimmu.2012.00209. PMID:2282671
Ouederni M, Vincent QB, Frange P, et al: Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood 2011;118(19):5108-5118.http://dx.doi.org/10.1182/blood-2011-05-352716.PMID: 21908431
Szczawinska-Poplonyk A, Kycler Z, Pietrucha B, Heropolitanska-Pliszka E, Breborowicz A, et al. The hyperimmunoglobulin E syndrome - clinical manifestation diversity in primary immune deficiency. JRareDis 2011 ;6:76. http://dx.doi.org/10.1186/1750-1172-6-76.PMID:22085750
Aghamohammadi A, Moghaddam ZG, Abolhassani H, Hallaji Z, Mortazavi H, Pourhamdi S, et al. Investigation of underlying primary immunodeficiencies in patients with severe atopic dermatitis. Allergol Immunopathol (Madr) 2014; 42(4):336-341. http://dx.doi.org/10.1016/j.aller.2013.02.004.PMID: 23735167
Chiam LY , Verhagen MM, Haraldsson A, Wulffraat N, Driessen GJ, Netea MG, Weemaes CM, Seyger MM, van Deuren M. Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: Reflection of inappropriate immune regulation? Dermatology 2011;223(1):13-19. http://dx.doi.org/10.1159/000330335. PMID:21876338
Carranza D, Vega AK, Torres Rusillo S, Montero E, Martinez LJ, Santamaría M, et al. Molecular and functional characterization of a cohort of Spanish patients with ataxia telangiectasia. Neuromolecular Med 2017; 19(1):161-174. http://dx.doi.org/10.1007/s12017-016-8440. PMID: 27664052
Greenberger S , Berkun Y, Ben-Zeev B, Levi YB, Barziliai A, Nissenkorn A. Dermatologic manifestations of ataxia-telangiectasia syndrome. J Am Acad Dermatol 2013 ;68(6):932-6. http://dx.doi.org/10.1016/j.jaad.2012.12.950. PMID:23360865
Dotta L, Parolini S, Prandini A, Tabellini G, Antolini M, Kingsmore SF, Badolato R . Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. Orphanet J Rare Dis 2013; 17(8):168. http://dx.doi.org/10.1186/1750-1172-8-168. PMID:24134793
Notarangelo LD .PIDs and cancer: an evolving story. Blood 2010;116(8):1189-1190. http://dx.doi.org/10.1182/blood-2010-06-286179.PMID:20798238
Mortaz E, Tabarsi P, Mansouri D, Khosravi A, Garssen J, Velayati A, Adcock IM. Cancers Related to Immunodeficiencies: Update and Perspectives. Front Immunol 2016;7:365. eCollection 2016 .http://dx.doi.org/ 10.3389/fimmu.2016.00365. PMID: 27703456
Mayor PC , Eng KH , Singel KL , Abrams SI , Odunsi K , Moysich KB , Fuleihan R, Garabedian E , Lugar P , Ochs HD , Bonilla FA , Buckley RH , Sullivan KE, Ballas ZK , Cunningham-Rundles C , Segal BH . Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol. 2018 ;141(3):1028-1035. http://dx.doi.org/10.1016/j.jaci.2017.05.024.
PMID:28606585
Naouel GUIRAT, Pediatric Immuno-Hematology Unit, Bone Marrow Transplantation Center Tunis, Tunis, Tunisia

Pediatric Immuno-Hematology Unit 

How to Cite



“CUTANEOUS MANIFESTATIONS OF PRIMARY IMMUNODEFICIENCY DISEASES IN TUNISIAN CHILDREN” (2018) Mediterranean Journal of Hematology and Infectious Diseases, 10(1), p. e2018065. doi:10.4084/mjhid.2018.065.